Compare BIO & MSGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | MSGS |
|---|---|---|
| Founded | 1952 | 1879 |
| Country | United States | United States |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Services-Misc. Amusement & Recreation |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 9.5B |
| IPO Year | N/A | 2015 |
| Metric | BIO | MSGS |
|---|---|---|
| Price | $319.82 | $397.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $339.75 | ★ $341.29 |
| AVG Volume (30 Days) | ★ 270.6K | 194.6K |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.74 | N/A |
| Revenue Next Year | $3.20 | $4.52 |
| P/E Ratio | $9.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $236.73 | $188.60 |
| 52 Week High | $343.12 | $411.73 |
| Indicator | BIO | MSGS |
|---|---|---|
| Relative Strength Index (RSI) | 66.82 | 58.91 |
| Support Level | $296.46 | $378.81 |
| Resistance Level | $325.65 | $409.74 |
| Average True Range (ATR) | 8.51 | 9.49 |
| MACD | 2.01 | -0.17 |
| Stochastic Oscillator | 96.86 | 64.40 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Madison Square Garden Sports Corp owns and operates a portfolio of assets featuring some of the recognized sports teams, including the Knicks of the NBA and the Rangers of the NHL. It generates revenue from several sources: ticket sales and a portion of suite rental fees at The Garden and others. It has one operating and reportable segment and one reporting unit for goodwill impairment testing purposes.